Patients News | pharmaphorum

News

MHRA pledges two-week review for low-risk clinical trials

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has implemented one part of its plan to reform the regulations governing clinical trials, namely an ini

News

Scotland first in Europe to back MSD drug for VHL tumours

Scotland has become the first country in Europe to recommend coverage of MSD’s Welireg as a treatment for some people with von Hippel-Lindau disease (VHL), a rare genetic

News

Public wants pharma to reveal carbon footprint of drugs

A survey has found that there is strong consumer support for pharma manufacturers to disclose the carbon footprint of their medicines, amid rising public scrutiny of the e

News

Roche app relieves diabetes distress in clinical trial

A digital health application (DiGA) has been shown to relieve the distress that patients can experience when managing diabetes, which can compromise their care, in a rando

News

AZ pays $425m to settle claims heartburn drugs caused harm

AstraZeneca confirmed this morning it has agreed to pay $425 million to settle lawsuits brought in the US that claim its heartburn therapies Nexium and Prilosec caused kid

News

WHO clears Oxford malaria jab for immunisation programmes

The World Health Organization (WHO) has recommended the use of a malaria vaccine developed at Oxford University in the UK, after concluding it is 75% effective at protecti

MHRA pledges two-week review for low-risk clinical trials

Scotland first in Europe to back MSD drug for VHL tumours

Public wants pharma to reveal carbon footprint of drugs

Roche app relieves diabetes distress in clinical trial

AZ pays $425m to settle claims heartburn drugs caused harm

WHO clears Oxford malaria jab for immunisation programmes

Senju launches first-in-class dry eye disease drug in Japan

Using AI-driven synthetic personas to take your insights fur...

News

Editor's Picks